Short Report

Get Permission
Rev Diabet Stud, 2011, 8(2):254-258 DOI 10.1900/RDS.2011.8.254

Insulin Pump Therapy is Equally Effective and Safe in Elderly and Young Type 1 Diabetes Patients

Bartlomiej Matejko1, Katarzyna Cyganek2, Barbara Katra2, Danuta Galicka-Latala1,2, Malgorzata Grzanka1, Maciej T. Malecki1,2, Tomasz Klupa1,2

1Department of Metabolic Diseases, Jagiellonian University, Medical College, 15 Kopernika Street, 31-501 Krakow, Poland
2University Hospital, Krakow, Poland
Address correspondence to: Tomasz Klupa, e-mail: tomasz.klupa@uj.edu.pl

Manuscript submitted June 12, 2011; resubmitted August 3, 2011; accepted August 5, 2011.

Keywords: type 1 diabetes, insulin pump, glycemic control, HbA1c, dual-wave bolus, bolus wizard, monitoring

Abstract

OBJECTIVES: It is generally accepted that in adult type 1 diabetes patients (T1D) continuous subcutaneous insulin infusion (CSII) via a personal pump is more effective than the multiple daily injections (MDI) model. However, it is not clear whether all age groups of adult T1D patients may equally benefit from CSII therapy. We aimed to compare the glycemic control and use of selected pump tools in T1D subjects using CSII over the age of 50 (50+ T1D) with patients younger than 50 years of age. METHODS: The last available insulin pump/blood glucose meter downloads and last available HbA1c levels of 124 adult T1D subjects using CSII were reviewed. We divided our cohort into two subgroups: 50+ T1D patients (n = 13) and younger patients (n = 111). RESULTS: There were no differences in glycemic control achieved with CSII treatment in 50+ T1D patients vs. younger subjects. HbA1c levels were 7.01 ± 0.67% and 7.34 ± 1.24% (p = 0.46), and the mean glycemia based on glucometer downloads was 141.8 ± 17.7 mg/dl and 150.8 ± 35.7 mg/dl (p = 0.69), respectively. Also, there were no differences with respect to the use of important personal pump options and tools. CONCLUSION: In conclusion, insulin pump therapy appears to be effective and safe in T1D patients regardless of age.

Fulltext: HTML , PDF (88KB)


This article has been cited by other articles:

Efficacy of Insulin Pump Therapy in Elderly Patients

Yeoh E, Beato-Vibora P, Rogers H, Amiel SA, Choudhary P

Diabetes Technol Ther 2015. In press

Management of Diabetes in the Elderly

Bansal N, Dhaliwal R, Weinstock RS

Med Clin North Am 2014. In press

Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment

Joubert M, Morera J, Vicente A, Rod A, Parienti JJ, Reznik Y

J Diabetes Sci Technol 2014. 8(5):1005-1010

Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps

Matejko B, Grzanka M, Kiec-Wilk B, Małecki MT, Klupa T

Ann Agric Environ Med 2013. 20(1):152-154

Efficacy and safety of insulin pump treatment in adult T1DM patients - influence of age and social environment

Grzanka M, Matejko B, Cyganek K, Kozek E, Małecki MT, Klupa T

Ann Agric Environ Med 2012. 19(3):573-575